Aims and Scope of Current Pharmaceutical Design
Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field. Less
Key Metrics
CiteScore 

5.8
H-Index 

176
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

0.73
Recommended pre-submission checks
Powered by 

Topics Covered on Current Pharmaceutical Design
Current Pharmaceutical Design Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Design ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Pharmaceutical Design
Machine Learning-Enabled Exploration of Bryophyllum Pinnatum Phytoconstituents for Urolithiasis Management: Molecular Docking, MMGBSA Analysis, ADMET Profiling, MD simulations, and Toxicity Assessment.
- 13 May 2026
- Current pharmaceutical design
Gabapentin and Pregabalin Overdoses and Their Management: An Update.
- 13 May 2026
- Current pharmaceutical design
Mechanistic Insights into Xihuang Wan against Bladder Cancer via PI3K/ AKT/BCL2-Mediated Apoptosis Inhibition: Integrated Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations and Experimental Validation.
- 13 May 2026
- Current pharmaceutical design
Extracellular Vesicles in Alzheimer's Disease: Mechanisms, Immunotherapy Links, and Clinical Translation.
- 13 May 2026
- Current pharmaceutical design
Cell-free DNA Methylation Analysis, a Noninvasive Biomarker for Detection, Prediction, Classification, and Treatment Monitoring for Brain Tumors.
- 12 May 2026
- Current pharmaceutical design
Efficacy of Pimpinella anisum L. in Menopausal Women with Psychological Symptoms: A Randomized Controlled Study Integrated with Machine Learning Analysis.
- 12 May 2026
- Current pharmaceutical design
Machine Learning-Enabled Exploration of Bryophyllum Pinnatum Phytoconstituents for Urolithiasis Management: Molecular Docking, MMGBSA Analysis, ADMET Profiling, MD simulations, and Toxicity Assessment.
- 13 May 2026
- Current pharmaceutical design
Gabapentin and Pregabalin Overdoses and Their Management: An Update.
- 13 May 2026
- Current pharmaceutical design
Mechanistic Insights into Xihuang Wan against Bladder Cancer via PI3K/ AKT/BCL2-Mediated Apoptosis Inhibition: Integrated Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations and Experimental Validation.
- 13 May 2026
- Current pharmaceutical design
Extracellular Vesicles in Alzheimer's Disease: Mechanisms, Immunotherapy Links, and Clinical Translation.
- 13 May 2026
- Current pharmaceutical design
Cell-free DNA Methylation Analysis, a Noninvasive Biomarker for Detection, Prediction, Classification, and Treatment Monitoring for Brain Tumors.
- 12 May 2026
- Current pharmaceutical design
Efficacy of Pimpinella anisum L. in Menopausal Women with Psychological Symptoms: A Randomized Controlled Study Integrated with Machine Learning Analysis.
- 12 May 2026
- Current pharmaceutical design